Answer
In the absence of specific studies, caution is advised when considering Medabon (mifepristone and misoprostol) in patients with renal or hepatic failure.
Sources for this answer
- Medabon - Combipack of Mifepristone 200 mg tablet and Misoprostol 4 x 0.2 mg vaginal tabletsRanbaxy (UK) Limited a Sun Pharmaceutical Company · emc · SmPC §4.4 Special warnings and precautions for use · Version 5Document updated
Sources checked